High materiality7/10
Ultragenyx price target lowered to $23 from $30 at Wedbush
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wedbush lowers RARE target to $23 from $30; current price $14.79; target remains above price, suggesting upside.
- Wedbush lowers RARE target to $23; price $14.79.
Key facts
- 01
Target: $23
- 02
Posted price: $14.79
- 03
Analyst firm: Wedbush
- 04
Analyst: Laura Chico
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.